Shibayama T - Search Results

1

Effect of gefitinib re-challenge to initial gefitinib responder with non-small cell lung cancer followed by chemotherapy.

Tomizawa Y, Fujita Y, Tamura A, Shirai M, Shibata S, Kawabata T, Shibayama T, Fukai S, Kawahra M, Saito R. Tomizawa Y, et al. Among authors: shibayama t. Lung Cancer. 2010 May;68(2):269-72. doi: 10.1016/j.lungcan.2009.06.025. Epub 2009 Aug 5. Lung Cancer. 2010. PMID: 19660826

2

Pilot study of cyclophosphamide-doxorubicin-vincristine-cisplatin-etoposide hybrid chemotherapy in small cell lung cancer.

Ohnoshi T, Hiraki S, Ueoka H, Kiura K, Kamei H, Horiguchi T, Kodani T, Maeda T, Tabata M, Shibayama T, et al. Ohnoshi T, et al. Among authors: shibayama t. Cancer. 1993 Sep 1;72(5):1597-601. doi: 10.1002/1097-0142(19930901)72:5<1597::aid-cncr2820720517>3.0.co;2-n. Cancer. 1993. PMID: 8394202 Clinical Trial.

3

Complementary roles of pro-gastrin-releasing peptide (ProGRP) and neuron specific enolase (NSE) in diagnosis and prognosis of small-cell lung cancer (SCLC).

Shibayama T, Ueoka H, Nishii K, Kiura K, Tabata M, Miyatake K, Kitajima T, Harada M. Shibayama T, et al. Lung Cancer. 2001 Apr;32(1):61-9. doi: 10.1016/s0169-5002(00)00205-1. Lung Cancer. 2001. PMID: 11282430

4

Fractionated administration of irinotecan and cisplatin for treatment of non-small-cell lung cancer: a phase II study of Okayama Lung Cancer Study Group.

Ueoka H, Tanimoto M, Kiura K, Tabata M, Takigawa N, Segawa Y, Takata I, Eguchi K, Okimoto N, Harita S, Kamei H, Shibayama T, Watanabe Y, Hiraki S, Harada M. Ueoka H, et al. Among authors: shibayama t. Br J Cancer. 2001 Jul 6;85(1):9-13. doi: 10.1054/bjoc.2001.1861. Br J Cancer. 2001. PMID: 11437395 Free PMC article. Clinical Trial.

5

Preoperative induction chemotherapy with cisplatin and irinotecan for pathological N(2) non-small cell lung cancer.

Date H, Kiura K, Ueoka H, Tabata M, Aoe M, Andou A, Shibayama T, Shimizu N. Date H, et al. Among authors: shibayama t. Br J Cancer. 2002 Feb 12;86(4):530-3. doi: 10.1038/sj.bjc.6600117. Br J Cancer. 2002. PMID: 11870532 Free PMC article. Clinical Trial.

6

Successful treatment of a patient with synchronous advanced non-small cell lung cancer and acute myeloid leukemia by a combination of gefitinib, low-dose cytarabine and aclarubicin.

Takigawa N, Takeuchi M, Shibayama T, Yoshida I, Kawata N, Tada A, Ueoka H, Takahashi K. Takigawa N, et al. Among authors: shibayama t. Anticancer Res. 2005 May-Jun;25(3c):2579-82. Anticancer Res. 2005. PMID: 16080496 Free article.

7

A phase I study of 3-day topotecan and cisplatin in elderly patients with small-cell lung cancer.

Fujiwara K, Ueoka H, Kiura K, Tabata M, Takigawa N, Hotta K, Umemura S, Sugimoto K, Shibayama T, Kamei H, Harita S, Okimoto N, Tanimoto M. Fujiwara K, et al. Among authors: shibayama t. Cancer Chemother Pharmacol. 2006 Jun;57(6):755-60. doi: 10.1007/s00280-005-0117-1. Epub 2005 Oct 6. Cancer Chemother Pharmacol. 2006. PMID: 16208519 Clinical Trial.

8

Interstitial lung disease in Japanese patients with non-small cell lung cancer receiving gefitinib: an analysis of risk factors and treatment outcomes in Okayama Lung Cancer Study Group.

Hotta K, Kiura K, Tabata M, Harita S, Gemba K, Yonei T, Bessho A, Maeda T, Moritaka T, Shibayama T, Matsuo K, Kato K, Kanehiro A, Tanimoto Y, Matsuo K, Ueoka H, Tanimoto M. Hotta K, et al. Among authors: shibayama t. Cancer J. 2005 Sep-Oct;11(5):417-24. doi: 10.1097/00130404-200509000-00010. Cancer J. 2005. PMID: 16259873

9

A phase I and pharmacological study of amrubicin and topotecan in patients of small-cell lung cancer with relapsed or extensive-disease small-cell lung cancer.

Shibayama T, Hotta K, Takigawa N, Tada A, Ueoka H, Harita S, Kiura K, Tabata M, Segawa Y, Nogami N, Kuyama S, Shinkai T, Tanimoto M. Shibayama T, et al. Lung Cancer. 2006 Aug;53(2):189-95. doi: 10.1016/j.lungcan.2006.05.008. Epub 2006 Jun 27. Lung Cancer. 2006. PMID: 16806573 Clinical Trial.

10

A triplet chemotherapy with cisplatin, docetaxel and gemcitabine in patients with advanced non-small-cell lung cancer: a phase I/II study.

Tabata M, Kozuki T, Ueoka H, Kiura K, Harita S, Tada A, Shibayama T, Takigawa N, Yonei T, Gemba K, Segawa Y, Kishino D, Tada S, Hiraki S, Tanimoto M; Okayama Lung Cancer Study Group. Tabata M, et al. Among authors: shibayama t. Cancer Chemother Pharmacol. 2007 Jun;60(1):53-9. doi: 10.1007/s00280-006-0346-y. Epub 2006 Sep 29. Cancer Chemother Pharmacol. 2007. PMID: 17009034 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

360 results

Search Page

Filters